Podcasts about clinical program director

In this Former Participant Series, Joanna interviews previously troubled teens and young adults who underwent a treatment program. Today, Joanna welcomes Bella. With incredible vulnerability, Bella shares about her pre-teen and teen years when she became an alcoholic and substance abuser, was admitted to a psych hospital, went to wilderness therapy, a therapeutic boarding school, and residential therapy - which ultimately led her to the work she does today: as a Clinical Program Director for an outpatient addiction treatment facility. NOTE: The podcasts in this series can include sensitive subjects such as suicide, self-harm, substance abuse, hospitalizations, psychotic episodes, and other traumatic experiences which include parts of the treatment journey. No topic is off limits and not all stories are positive but they are real, raw, and transparent. **Listener discretion is advised**Connect with Joanna LilleyLilley Consulting WebsiteLilley Consulting on Facebook Lilley Consulting on YouTubeEmail: joanna@lilleyconsulting.com#therapeuticconsulting #lilleyconsulting #successful #alcoholism #substanceabuse #pyschhospital #mentalhealth #transition #wildernesstherapy #therapeuticboardingschool #healing #sobriety #inspiration #successissubjective #pfcaudiovideo 

https://www.advancedpracticeproviders.com/ https://www.antiherosjourney.com/ This is Part 2 of our interview with Lyndsey Ryan, Clinical Program Director at TARA Mind (a ketamine-assisted therapy network). Yesterday's episode was an interview prior to her trip to The Mission Within in Mexico for an Ibogaine and 5MeO-DMT assisted course of therapy. Today, she answers the same questions from her perspective on the other side of this intensive treatment experience. You won't want to miss this episode! https://www.navigatesni.com/free-consultation

https://www.advancedpracticeproviders.com/ https://www.antiherosjourney.com/ Lyndsey Ryan is the Clinical Program Director at TARA Mind. A Licensed Professional Counselor (LPC) and Licensed Addictions Counselor (LAC), Lyndsey has spent 25 years performing research, training, and developing hybrid modality support so she can best support her clients in finding a safe refuge in their own mind and body. Lyndsey has trained in Ketamine-Assisted Psychotherapy, IFS, somatic psychotherapies including Somatic Experiencing, attachment work, art therapy, and advanced EMDR techniques to support people struggling with early childhood neglect and abuse, addictions, combat trauma, and self-harming/self-defeating behaviors and thoughts. Lyndsey graduated from Naropa University with her Master of Arts in Contemplative Psychotherapy and utilizes a broader contemplative lens as well as a Tibetan Buddhism lens in her work. https://www.navigatesni.com/free-consultation

In this episode, Dr. Wassim McHayleh, Clinical Program Director for the Breast Cancer Program, AdventHealth Cancer Institute shares insights into his background, AdventHealth's Breast Multidisciplinary (MCD) Model, how the model benefits both patients and providers, advice for other systems adopting this model, and more.

Laura Harward, MSW, LICSW has been the director of the Intensive Clinical Program (ICP) - Home Base's signature program for the past 4 years. In 2015 while working in research at Mass General Hospital, she saw the need for veteran and military family care, and so Home Base was lucky to bring her on board. Laura always has a pulse on the Home Base program, and she shares where it has been, where it is now, and where it is going. Thanks for joining us for this special conversation – Home Base Nation correspondent Chuck Clough brings us this interview with Home Base's very own, Laura Harward._____If you are your loved one is experiencing any emotional, mental health struggles, you are not alone and please contact Home Base at (617) 724-5202, or visit www.homebase.org.REMINDER... If you are a runner, walker, or want to sponsor either one, the 14th annual Run To Home Base is coming soon, of course back at Fenway Park with our great partners the Red Sox Foundation, on Saturday July 22nd 2023! Thank you for all your support of the mission to take care of all of our veterans their families. This year we will highlight and honor the Special Operators, including our Navy SEAL, Green Beret, Ranger, Delta force and other communities. Hope to see you there and as always you can join, run and support anywhere virtually…At runtohomebase.orgTheme music for Home Base Nation: "Rolling the tree" by The Butler FrogsFollow Home Base on Twitter, Facebook, Instagram, LinkedInThe Home Base Nation Team is Steve Monaco, Army Veteran Kelly Field, Phebe Garver, Justin Scheinert, Chuck Clough, with COO Michael Allard, Brigadier General Jack Hammond, and Peter Smyth.Producer and Host: Dr. Ron HirschbergAssistant Producer, Editor and corresponded (Home Base Staff Picks): Chuck CloughChairman, Home Base Media Lab: Peter SmythTo Donate to Home Base where every dollar goes to the care of veterans and military families that is cost to them, go to: www.homebase.org/donate.Home Base Nation is the official podcast of Home Base Program for Veterans and Military Families, a partnership of the Massachusetts General Hospital and the Red Sox Foundation. To learn more and connect with us at Home Base Nation: www.homebase.org/podcastThe views expressed by guests to the Home Base Nation podcast are their own and their appearance on the program does not imply an endorsement of them or any entity they represent. Views and opinions expressed by guests are those of the guests and do not necessarily reflect the view of the Massachusetts General Hospital, Home Base, the Red Sox Foundation or any of its officials.

A Naval Officer, Nurse, Lawyer, Educator, Leader. Paula Neira's career spans an incredible set of experiences and professions. She wanted nothing more than to command a ship at sea, but her Naval career was cut short by the need to live authentically well before transgender people could do both. Find out how she developed that still-burning desire to serve into a career in medicine, law, and education that knocked down barriers for others to reach their full potential. Guest Biography Paula M. Neira is originally from Jersey City, New Jersey, and graduated from Regis High School in New York City. A member of the United States Naval Academy Class of 1985, she graduated with distinction from Annapolis in May 1985. A Surface Warfare Officer, she served as a regular and reserve officer including serving in mine warfare combat during Operation Desert Storm. Her military decorations include three Navy Commendation Medals, the Navy Achievement Medal, and the Combat Action Ribbon, as well as numerous unit, campaign, and service awards. After leaving the Navy in 1991, she began her career as a registered nurse. She is certified in emergency nursing and focused her career on adult emergency care and trauma resuscitation. From 2008-2016, Paula served as the Nurse Educator in Emergency Medicine at The Johns Hopkins Hospital. She also served as the co-chair of the Johns Hopkins Transgender Medicine Executive Taskforce. In November 2016, she became the founding Clinical Program Director of the Johns Hopkins Center for Transgender Health and served in this role 2016-2022. In March of 2022, she was named as the Johns Hopkins Medicine Program Director of LGBTQ+ Equity and Education in the Office of Diversity, Inclusion and Health Equity. An attorney and member of the Maryland bar since 2001, Paula was a leader in the repeal of the Don't Ask, Don't Tell policy and in the change of military regulations to allow for transgender military service. As part of her role at Hopkins, she lectures nationally on the need for improved transgender cultural awareness and health equity. In 2015, she made naval history by becoming the first transgender Navy veteran to have her discharge documentation updated to reflect her correct name by order of the Navy. In 2016, the Secretary of the Navy named her to be the co-sponsor of the USNS HARVEY MILK (T-AO-206) and in November 2021, she christened the ship in San Diego. In 2018, she was awarded the GLMA Achievement Award and in 2020, she was inducted as a Fellow into the American Academy of Nursing in recognition of her leadership in advancing diversity and inclusion both in the United States Armed Forces and in healthcare. She is the first United States service academy graduate to achieve this honor in American nursing. Paula and her partner reside in Bowie, Maryland.

Holiday Replays! Best Of Series...In this weeks episode Amy and Katie chat with dentist to the stars, Dr. Jon Marashi.  The three discuss dental care and the brushing basics, yay or nay to mouth wash, teeth whitening, and more. Dr. Marashi shares the most requested cosmetic treatments from Hollywood A listers and the three do a deep dive on cosmetic procedure, porcelain veneers.About Dr. MarashiAn industry leader and innovator, Dr. Jon Marashi excels in artistic dental restoration that is highly customized to meet the needs of his patients. He personally hand sculpts each smile using microscope precision to create a remarkably natural aesthetic, garnering him industry-wide accolades and a loyal patient following. Among his professional accomplishments, Dr. Marashi graduated from the Honors Aesthetic Dentistry program at New York University College of Dentistry, where he would later become a Clinical Instructor in Aesthetic Advantage. He also served as Clinical Program Director at California Center for Advanced Dental Studies and as a Clinical Consultant to a major dental manufacturer, where he advised on the development of new products and materials.Before this list of professional accomplishments, Jon was curious about dentistry after seeing a close friend's father in action while performing dental work on Jon himself at a young age.  After paying out of pocket for his own work, this would be how Jon would move through this journey of becoming a Doctor, working hard, investing in himself until he could begin to realize his own dreams.  Now, he wants to enjoy the life he worked hard for, live joyfully, create a life of legacy, while being present and healthy in it and share his life methods with those that see an existence outside of their current circumstances.  Follow @drjonmarashi on IGConnect with Dr. MarashiFind us at www.nirvanasisters.comFollow us @nirvanasisters on InstagramSay hi at hello@nirvanasisters.comPlease subscribe, rate, review and share

In this weeks episode Amy and Katie chat with dentist to the stars, Dr. Jon Marashi.  The three discuss dental care and the brushing basics, yay or nay to mouth wash, teeth whitening, and more. Dr. Marashi shares the most requested cosmetic treatments from Hollywood A listers and the three do a deep dive on cosmetic procedure, porcelain veneers. About Dr. MarashiAn industry leader and innovator, Dr. Jon Marashi excels in artistic dental restoration that is highly customized to meet the needs of his patients. He personally hand sculpts each smile using microscope precision to create a remarkably natural aesthetic, garnering him industry-wide accolades and a loyal patient following. Among his professional accomplishments, Dr. Marashi graduated from the Honors Aesthetic Dentistry program at New York University College of Dentistry, where he would later become a Clinical Instructor in Aesthetic Advantage. He also served as Clinical Program Director at California Center for Advanced Dental Studies and as a Clinical Consultant to a major dental manufacturer, where he advised on the development of new products and materials.Before this list of professional accomplishments, Jon was curious about dentistry after seeing a close friend's father in action while performing dental work on Jon himself at a young age.  After paying out of pocket for his own work, this would be how Jon would move through this journey of becoming a Doctor, working hard, investing in himself until he could begin to realize his own dreams.  Now, he wants to enjoy the life he worked hard for, live joyfully, create a life of legacy, while being present and healthy in it and share his life methods with those that see an existence outside of their current circumstances.  Follow @drjonmarashi on IGConnect with Dr. MarashiFind us at www.nirvanasisters.comFollow us @nirvanasisters on InstagramSay hi at hello@nirvanasisters.comPlease subscribe, rate, review and share

Guest host Dr. Neeraj Agarwal, of the University of Utah Huntsman Cancer Institute and the ASCO Daily News editor-in-chief, discusses key therapeutic advances in mRCC and mUC, as well as new research that proposes periodic scans to monitor patients with mCSPC for disease progression, with Dr. Jeanny-Aragon-Ching of the Inova Schar Cancer Institute.  Transcript:  Dr. Neeraj Agarwal: Hello and welcome to the ASCO Daily News podcast. I'm Dr. Neeraj Agarwal, the director of the Genitourinary Oncology Program, a professor of medicine at the University of Utah Huntsman Cancer Institute, and editor-in-chief of the ASCO Daily News.  My guest today is Dr. Jeanny Aragon-Ching, who is a medical oncologist and the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute in Virginia.  Today, we will be discussing key posters in genitourinary (GU) oncology that will be featured at the 2022 ASCO Annual Meeting. Our full disclosures are available in the show notes and disclosures of all guests on the podcast can be found on our transcripts at asco.org/podcast.  Jeanny, it is great to have you on the podcast today.  Dr. Jeanny Aragon-Ching: Thanks, Neeraj. It's a pleasure for me to be here as well.  Dr. Neeraj Agarwal: Jeanny, let's begin with Abstract 4510. This is a trial that represents a growing interest among researchers worldwide in the microbiome and how it is impacted by antibiotics and how it modulates immune checkpoint inhibitor response. Can you tell us about this study?  Dr. Jeanny Aragon-Ching: Thanks, Neeraj, I would be happy to. So, the title of the abstract is, “Characterization of the Microbial Resistome in a Prospective Trial of CBM 588 in Metastatic Renal Cell Carcinoma Offers Mechanism for Interplay Between Antibiotic Use and Immune Checkpoint Inhibitor Activity.”  So, this is an interesting abstract that originated likely from the observation that getting antibiotics while on checkpoint inhibitors typically results in worse outcomes, perhaps because antibiotics can clear the normal gut flora and thereby increase these pathogenic antibiotic-resistant bacteria.  Now, on the other hand, there were some retrospective studies using a live microbial product called CBM 588, which seems to improve outcomes in patients on checkpoint inhibitors and getting antibiotics.  So, the idea, therefore, is that shifting the genes encoding antimicrobial resistance could result in a better checkpoint inhibitor response. So, this Abstract 4510 is a small study conducted by Dr. Nazli Dizman and Dr. Sumanta (Monty) Kumar Pal, and colleagues, and enrolled 29 metastatic clear cell RCC patients with intermediate or poorest disease. And they were stratified into receiving either nivolumab or ipilimumab compared to nivo/IPI with CBM 588.  Now stool samples were collected at baseline in week 12. And they did this whole metagenome sequencing to analyze a stool microbiome composition, and they also looked at the antibiotic resistance genes for the most common classes of antibiotics.  The results showed an astounding improvement in objective responses. So, 58%, for instance, in nivo/IPI and the CBM 588 arm compared to only 20% in the nivo/IPI arm. And it seems like also the antibiotics resistance genes were also decreased in those getting the CBM 588 alongside nivo/IPI. Therefore, responses were improved by shifting the gut microbiome alone. So, these findings were published actually recently by these authors in Nature Medicine. So, in case anyone wants to take a deep dive, it would be a good interesting read for this dataset.  Dr. Neeraj Agarwal: Very interesting, indeed. Jeanny, what is the main message here for our colleagues?  Dr. Jeanny Aragon-Ching: I think, Neeraj, the key takeaway message is that this is a very provocative proof of concept trial that suggests shifting the gut microbiome has the potential to improve responses to checkpoint inhibitors and outcomes. So, this is a very up-and-coming trial and is seen also across the board in other cancers.  Dr. Neeraj Agarwal: Thanks, Jeanny. Moving on to urothelial cancer, there is a poster that I think is a must-see for our colleagues. This is Abstract 4577 titled, “Defining Platinum Ineligible Patients with Metastatic Urothelial Carcinoma.”  Dr. Jeanny Aragon-Ching: So, Neeraj, what can you tell us about this abstract?  Dr. Neeraj Agarwal: So, over the past few years, there has been a tremendous evolution in the treatment landscape for patients with metastatic urothelial carcinoma. For over 40 years the standard of care for these patients has been cisplatin-based chemotherapy.  However, approximately 50% of patients are cisplatin-ineligible, due to underlying comorbidities, and are offered carboplatin as an alternative. So, although the checkpoint inhibitors pembrolizumab and atezolizumab were approved as first-line therapy for these patients in 2017, the U.S. Food and Drug Administration (FDA) has now restricted the use of first-line pembrolizumab to platinum ineligible patients with metastatic urothelial carcinoma.  The challenge we face as oncologists since the FDA restriction is the absence of a formal definition of platinum ineligibility and the inclusion of this definition in the guidelines. So, in Abstract 4577, Drs. Shilpa Gupta and Jonathan Rosenberg, along with the team present an updated consensus definition for platinum ineligibility based on an online survey of 60 genitourinary oncologists in the United States.  Based on the results from this survey, any patient with metastatic urothelial carcinoma, meeting 1 of the following 5 clinical and or laboratory parameters should be considered platinum ineligible, and these are 1 of the following: an ECOG performance status of 3 or more, creatinine clearance of fewer than 30 mils per minute, or peripheral neuropathy of grade 2 or more, or heart failure class of 3 or more—so, this is NYHA heart failure class of 3 or more—and lastly, the combination of performance status of 2 or more, plus a creatinine clearance of less than 30 mils per minute.  Dr. Jeanny Aragon-Ching: Well, this is a timely update, Neeraj. So, what do you think is a key takeaway from this abstract?  Dr. Neeraj Agarwal: These criteria based on simple and easily available clinical and or laboratory parameters will now allow us to readily define platinum ineligibility in our patients with metastatic urothelial carcinoma, which is a need in busy clinics, both in academic and community settings.  So, I think once published and obviously once endorsed by guidelines, we really would like to be able to use this criterion to quickly define platinum ineligibility in our clinics.  Dr. Jeanny Aragon-Ching: Agree. Yeah.  Dr. Neeraj Agarwal: So, Jeanny, let me switch the gears. PSMA testing is a hot topic this year. And there is an abstract that could potentially have an impact on future guidelines, and how we will practice further down the road.  So, I'm referring to the Abstract 5088 titled, “Predictive Value of Extra Prostatic Disease Detection by Preoperative PSMAPET for Biochemical Recurrence-free Survival in Patients with Otherwise Localized Prostate Cancer and Who are Treated with Radical Prostatectomy.”  So, this is a follow-up analysis of a multicenter prospective phase 3 imaging trial. So, could you please tell us more about this abstract where they are using PSMA PET scan in the preoperative localized prostate cancer setting?  Dr. Jeanny Aragon-Ching: Absolutely, Neeraj. So, you may recall that the multicenter prospective phase 3 imaging trial that garnered gallium PSMA approval by the FDA was actually based on this study that looked at the intermediate and high-risk patients with prostate cancer undergoing radical prostatectomy and lymph node dissection, and they underwent prior gallium PSMA PET scanning for pelvic nodal metastases prior to surgery.  So, this was actually previously reported by Dr. Calais and group. Now they are reporting on Abstract 5088 as a post hoc analysis of the same population and group of patients looking for extraprostatic disease. And the final pathology was also correlated to look at nodal disease in these patients in order to predict biochemical recurrence, so they follow these patients for biochemical recurrence occurrence.  So, of the 36% of patients who did undergo radical prostatectomy after they underwent PSMA PET scan, about 41% of them recurred with biochemical recurrence, and 40% of them underwent some kind of salvage therapy or some treatment.  What was very interesting was when they looked at the biochemical recurrence-free survival. It was better in those who were PSMA negative, and that recurrence-free survival was easily about 33 months, compared to only about 7.3 months in those who were PSMA-positive scans.  Furthermore, the ones who had the longest and the highest biochemical recurrence-free survival, intuitively, were those who were node-negative and PSMA PET-negative, so probably not surprisingly. And that rate was about 46 months—close to 4 years. Whereas those who are node-positive on final pathology and their PSMA PET was also positive, they only had about 3 months of biochemical recurrence-free survival.  Dr. Neeraj Agarwal: Very interesting. So, it looks like the PSMA PET scan is predicting biochemical recurrence-free survival in localized prostate cancer settings. So, Jeanny, what is the key takeaway from this trial?  Dr. Jeanny Aragon-Ching: I think, Neeraj, the bottom line is that patients with extraprostatic disease that is detected by their preoperative PSMA PET scan does predict strongly a high risk of biochemical relapse, and this can really be an additional tool that clinicians can use to help inform and guide future therapy.  Dr. Neeraj Agarwal: Thanks, Jeanny. The research on preoperative PSMA testing and its implications on future treatment strategies in the setting is going to be really interesting to watch in the very near future.  Dr. Jeanny Aragon-Ching: Yes, absolutely. I really think we should also discuss Abstract 5072, along those lines, the importance really of radiographic monitoring for disease progression in patients with metastatic hormone-sensitive prostate cancer.  Dr. Neeraj Agarwal: Yes, thanks for reminding and this is Abstract 5072. This is a post hoc analysis of the ARCHES trial, titled, “Radiographic Progression in the Absence of PSA Progression in Patients with Metastatic Hormone-sensitive Prostate Cancer.”  During the last several years, we have seen many of these agents typically given for gastric resistant prostate cancer moving upfront to the castration-sensitive prostate cancer setting. This is especially true for androgen receptor access targeting agents such as abiraterone, enzalutamide, and apalutamide, all being now approved for patients with metastatic castration-sensitive prostate cancer.  What is noteworthy from all these trials, and is reported in Abstract 5072, is the use of imaging studies to evaluate disease progression. So, in Abstract 5072, Dr. Andrew Armstrong and Dr. Arun Azad performed a post hoc analysis of the ARCHES trial to investigate the concordance between radiographic progression and the PSA Progression as defined by PCWG2 criteria, or between radiographic progression and any rise in the PSA above nadir, in patients who were being treated with this novel hormonal therapies, in this case, enzalutamide for metastatic castration sensitive prostate cancer.  And as a quick reminder, ARCHES was a phase 3 trial that showed a significant reduction and radiographic progression-free survival and improved overall survival for patients with metastatic castration sensitive prostate cancer treated with enzalutamide plus androgen deprivation therapy (ADT) versus those treated with placebo plus androgen deprivation therapy.  So, very interestingly, the findings from this study indicate that 67% of patients on the enzalutamide plus ADT arm did not have [Prostate Cancer Clinical Trials Working Group 2 criteria] PCWG2-defined prostate-specific antigen (PSA) progression at the time of radiographic progression. And discordance was present in the ADT-only arm as well, where they found 42% of patients on the ADT-only arm had radiographic progression but did not have PCWG2-defined PSA progression.  Interestingly, this discordance of radiographic disease progression was also seen with any rise in the PSA above nadir. And I personally found this information to be very clinically relevant when we are seeing the majority of patients actually experiencing radiographic disease progression, not experiencing PSA progression at the same time.  Dr. Jeanny Aragon-Ching: Yeah, absolutely. I agree with that, Neeraj. So, very interesting data. So, what do you think is the key takeaway message for the clinicians listening to us?  Dr. Neeraj Agarwal: I'll make the message very simple. I think the message is that patients with metastatic castration-sensitive prostate cancer need to be monitored for disease progression with periodic scans, and PSA monitoring alone is not sufficient in the majority of these patients.  Again, we cannot undervalue the role of periodic imaging studies in these patients so that we can timely diagnose them to have disease progression.  Dr. Jeanny Aragon-Ching: I agree with that.  Dr. Neeraj Agarwal: Jeanny, the last abstract I would like to mention before we wrap up the podcast is Abstract 4509, the results from the phase1 live SPARC 001 study. So, can you please tell us more about this study titled, “Phase-1 Live SPARC 001: The Study of Belzutifan in Advanced Solid Tumors,” which is an update of the renal cell carcinoma cohort with more than 3 years of total follow up?  Dr. Jeanny Aragon-Ching: Thanks, Neeraj. So, while the current therapeutic landscape for patients with metastatic clear cell renal cell carcinoma (RCC) has changed dramatically over the past several years, with significant improvement in patient outcomes. Most patients unfortunately still experience disease progression on current treatments.  So, in-depth molecular profiling of clear cell RCC has revealed recurrent loss of function mutations in VHL in actually greater than 90% of patients. So, the VHL protein, as you will recall, is part of the oxygen-sensing pathway, regulating levels of HIF which is hypoxia-inducible factor protein, it's a transcriptional activator that mediates the response to hypoxic conditions. So, HIF-2α is a key oncogenic driver in RCC.  So, previous data you may recall from the phase-1 Live SPARC 001 trial was designed to evaluate belzutifan so, this was a novel HIF-2α inhibitor which showed durable anti-tumor activity and acceptable safety profile in patients with metastatic clear cell RCC.  So, in Abstract 4509, Drs. Jonasch and Toni Choueiri presented updated results from this trial after more than 3 years of follow-up. Of the 55 patients enrolled 16% of patients remained in treatment. And 62% of patients had discontinued treatment because of, unfortunately, disease progression.  The median progression-free survival (PFS) for the total cohort was 14.5 months. And the overall disease control rate was 80%. Forty percent of patients experienced grade 3 treatment-related adverse events with the most frequent ones being anemia and hypoxia.  There were no great 4 or 5 treatment-related adverse events. And these results, therefore, show that belzutifan monotherapy continues to show a high rate of disease control and a safety profile in a heavily treated population of patients with metastatic RCC. So, it is great to see that there were no new safety signals.  Dr. Neeraj Agarwal: Very nice data indeed. So, Jeanny, what is the key takeaway message here for our listeners?  Dr. Jeanny Aragon-Ching: Yeah, I think the message here is that the use of belzutifan monotherapy continues to show efficacy and safety in patients with metastatic clear cell RCC, which have progressed on multiple prior contemporary therapies, and there are phase 3 trials currently underway.  Dr. Neeraj Agarwal: Jeanny, any final thoughts before we wrap up the podcast today?  Dr. Jeanny Aragon-Ching: Thanks, Neeraj. I think it's a really exciting time to be in genitourinary (GU) oncology, and I'm truly looking forward to seeing some great sessions at the 2022 ASCO Annual Meeting.  Dr. Neeraj Agarwal: Thank you, Jeanny, for sharing your insight with us today. It was a great conversation. And thank you to our listeners for joining us today. You will find links to the abstracts discussed today on the transcript of this episode. Finally, if you value the insights that you hear on the ASCO Daily News podcast, please take a moment to rate, review, and subscribe wherever you get your podcast.    Disclosures:   Dr. Neeraj Agarwal:   Consulting or Advisory Role: Pfizer, Bristol-Myers Squibb, AstraZeneca, Nektar, Lilly, Bayer, Pharmacyclics, Foundation Medicine, Astellas Pharma, Lilly, Exelixis, AstraZeneca, Pfizer, Merck, Novartis, Eisai, Seattle Genetics, EMD Serono, Janssen Oncology, AVEO, Calithera Biosciences, MEI Pharma, Genentech, Astellas Pharma, Foundation Medicine, and Gilead Sciences  Research Funding (Institution): Bayer, Bristol-Myers Squibb, Takeda, Pfizer, Exelixis, Amgen, AstraZeneca, Calithera Biosciences, Celldex, Eisai, Genentech, Immunomedics, Janssen, Merck, Lilly, Nektar, ORIC Pharmaceuticals, crispr therapeutics, Arvinas  Dr. Jeanny Aragon-Ching:   Honoraria: Bristol-Myers Squibb, EMD Serono, Astellas Scientific and Medical Affairs Inc  Consulting or Advisory Role: Algeta/Bayer, Dendreon, AstraZeneca, Janssen Biotech, Sanofi, EMD Serono, AstraZeneca/MedImmune, Bayer, Merck, Seattle Genetics, Pfizer, Immunomedics, Amgen, AVEO, Pfizer/Myovant, Exelixis  Speakers' Bureau: Astellas Pharma, Janssen-Ortho, Bristol-Myers Squibb , Astellas/Seattle Genetics  Travel, Accommodations, Expenses: Dendreon, Algeta/Bayer, Bristol Myers Squibb, EMD Serono, Astellas Pharma  Disclaimer:   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.  Guests on this podcast expressed their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.       

In this episode, we talk to Licensed Professional Counselor Erica Johns as she explains:What nonsuicidal self-harm and Anorexia areSigns to look forWhat to do about it. Visit SandstoneCare.com or call (888) 850-1890 for teen and young adult support. Learn more about self-harmLearn more about eating disordersErica Johns serves as the Clinical Program Director for the Reston location of Sandstone Care. Erica holds a Bachelor's Degree in Psychology and Criminal Justice along with a Master's Degree in Mental Health Counseling. Erica is a Licensed Professional Counselor in Virginia. Erica has several years of clinical experience, including individual, family, and group therapy. Erica has worked in both Residential and Intensive Outpatient settings and holds experience in outpatient settings. Erica is trained in Trauma Focused Cognitive Behavioral Therapy, Family Based Therapy and has extensive experience with both DBT and CBT.

In this episode Samantha Satchell, Clinical Program Director at VOA, shares  her own journey of turning traumatic events into a springboard into positive change. I believe that this conversation will bless you as Samantha points to the hope available for us all. - - - At Volunteers of America Northern Rockies we engage those we serve with an intentional focus that meets needs, educates, uplifts and inspires. We also recognize how much we all need to hear positive stories of lives transformed. That's why we created Recovery Podcast. Recovery Podcast is a collection of interviews designed to share stories of recovery and faith from Volunteers of America Northern Rockies past and present. It is our honor to share them with a belief they will enlighten and encourage. From amazing testimonies of hope to educating around serving our community in need, our podcast will inform, engage and inspire.There are so many powerful stories to be told from our amazing, rich history. And that's the point of this podcast. H.G. Wells said that human history is the history of ideas. Some of those ideas are of course based around our growth in technology and structure. Yet, many ideas have been inspired by faith to help humanity overcome the physical, mental and spiritual challenges of life. We want to share our ideas with you because we know they've helped restore countless lives. Many of our leaders are among the top professionals in their field, navigating their teams through the changing landscape of human services. In the coming months we'll hear interviews from many of them, sharing their expertise in the world of addiction treatment, homeless services, veteran support, moral injury and so much more. We also have a diverse portfolio of partners that have joined forces with us to provide practical self-care education, spiritual direction and helped bring deeper understanding of what it means to be true servant leaders. We will bring you special interviews with many of our current and past partners, offering insight into how they helped us grow, and we trust it will help many of you as well.Today's music is courtesy of Free Music Archive. This week you heard tunes by Ketsa who also composed our theme music. 

Special guests: Alan Ehrlich, Executive Editor at DynaMed and an Associate Professor in Family Medicine at the University of Massachusetts Medical School in Worcester Bio: Alan Ehrlich, MD, FAAFP is the Executive Editor at DynaMed and an Associate Professor in Family Medicine at the University of Massachusetts Medical School in Worcester. He is board certified from the American Board of Family Medicine and a Fellow of the American Academy of Family Physicians. Alan graduated from Rutgers New Jersey Medical School in 1984 and completed his residency at the University of Massachusetts Medical Center in 1987. He is involved in the teaching of Evidence-Based Medicine to third year medical students and writes the Evidence-Based Medicine column for Clinical Advisor magazine.  Eileen Yoshida, Deputy Editor of Medication and Clinical Informatics, EBSCO Health Bio: Eileen Yoshida is the Deputy Editor of Medication and Clinical Informatics at EBSCO Health. In this role, she leads the medication and clinical informatics strategies for the organization. Eileen brings over 25 years of experience in the healthcare industry, most recently leading the Clinical Knowledge Management and Decision Support team at Partners HealthCare. Previously, she served with Capgemini as an EHR implementation strategist and with the University of Chicago Hospitals in a special project's role. Eileen has extensive experience in clinical informatics, EHR implementation, healthcare          consulting and clinical pharmacy and is a published author and speaker on clinical decision support. She holds a degree in Pharmacy from the University of Toronto and a master's in business administration from the Kellogg School of Management at Northwestern University.  Research: Report from HIMSS19: Novel Techniques to Combat the Opioid Misuse Epidemic Courtney Holmes, RN, Executive Clinical Consultant, IBM Watson Health Bio: Courtney Holmes is a Clinical Program Director supporting IBM's Micromedex solution suite, as well as an Executive Clinical Consultant with Watson Health. Courtney focuses on providing clinical leadership in the sales and development of cognitive solutions and engagement with key stakeholders to support meaningful use of Watson Health solutions. She provides subject matter expertise for the Healthcare. Provider Segment. This includes providing strategic and clinical expertise to ensure high value development/improvements and intuitive, seamless clinical workflow design. Courtney collaborates among global product offerings teams to ensure clinically relevant approaches to client engagements, and leads Watson Health solution sales activities through client briefings, demonstration of solutions, workshops and other formats as needed.  Ms. Holmes joined IBM in 2018 and brings 17 years of extensive oncology nursing experience to the team. Her experience ranges from direct clinical care at some of the top hospitals in the country, to developing the nurse educator program for a large pharmaceutical company and leading a team of nurses in her region. Courtney spent time building strong customer relationships with key nursing organizations, targeted accounts, and other identified key customers. She also focused on providing clinical expertise and support to sales to optimize overall customer experience, as well as helping facilities achieve better patient outcomes by improving overall quality of care and providing insight on best practices. Blog post: https://www.ibm.com/blogs/watson-health/how-ai-infused-clinical-decision-support-may-change-medicine/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Special guests: Alan Ehrlich, Executive Editor at DynaMed and an Associate Professor in Family Medicine at the University of Massachusetts Medical School in Worcester Bio: Alan Ehrlich, MD, FAAFP is the Executive Editor at DynaMed and an Associate Professor in Family Medicine at the University of Massachusetts Medical School in Worcester. He is board certified from the American Board of Family Medicine and a Fellow of the American Academy of Family Physicians. Alan graduated from Rutgers New Jersey Medical School in 1984 and completed his residency at the University of Massachusetts Medical Center in 1987. He is involved in the teaching of Evidence-Based Medicine to third year medical students and writes the Evidence-Based Medicine column for Clinical Advisor magazine.  Eileen Yoshida, Deputy Editor of Medication and Clinical Informatics, EBSCO Health Bio: Eileen Yoshida is the Deputy Editor of Medication and Clinical Informatics at EBSCO Health. In this role, she leads the medication and clinical informatics strategies for the organization. Eileen brings over 25 years of experience in the healthcare industry, most recently leading the Clinical Knowledge Management and Decision Support team at Partners HealthCare. Previously, she served with Capgemini as an EHR implementation strategist and with the University of Chicago Hospitals in a special project's role. Eileen has extensive experience in clinical informatics, EHR implementation, healthcare          consulting and clinical pharmacy and is a published author and speaker on clinical decision support. She holds a degree in Pharmacy from the University of Toronto and a master's in business administration from the Kellogg School of Management at Northwestern University.  Research: Report from HIMSS19: Novel Techniques to Combat the Opioid Misuse Epidemic Courtney Holmes, RN, Executive Clinical Consultant, IBM Watson Health Bio: Courtney Holmes is a Clinical Program Director supporting IBM's Micromedex solution suite, as well as an Executive Clinical Consultant with Watson Health. Courtney focuses on providing clinical leadership in the sales and development of cognitive solutions and engagement with key stakeholders to support meaningful use of Watson Health solutions. She provides subject matter expertise for the Healthcare. Provider Segment. This includes providing strategic and clinical expertise to ensure high value development/improvements and intuitive, seamless clinical workflow design. Courtney collaborates among global product offerings teams to ensure clinically relevant approaches to client engagements, and leads Watson Health solution sales activities through client briefings, demonstration of solutions, workshops and other formats as needed.  Ms. Holmes joined IBM in 2018 and brings 17 years of extensive oncology nursing experience to the team. Her experience ranges from direct clinical care at some of the top hospitals in the country, to developing the nurse educator program for a large pharmaceutical company and leading a team of nurses in her region. Courtney spent time building strong customer relationships with key nursing organizations, targeted accounts, and other identified key customers. She also focused on providing clinical expertise and support to sales to optimize overall customer experience, as well as helping facilities achieve better patient outcomes by improving overall quality of care and providing insight on best practices. Blog post: https://www.ibm.com/blogs/watson-health/how-ai-infused-clinical-decision-support-may-change-medicine/ Learn more about your ad choices. Visit megaphone.fm/adchoices

How the use and training of AI-based medication management will impact hospital pharmacy. IBM® Micromedex® with Watson™ combines evidence-based drug content with advanced AI search capabilities to deliver rapid, reliable answers at the point of care. Improve care experiences and efficiency with insights into drug selection, dosing, toxicology and IV compatibility – accessible from your EHR, computer or mobile device. Primer, 101 for AI in Pharmacy – terminology, examples in med use process Augmented intelligence vs. Artificial intelligence, leveraging the strengths of computers and clinicians together to obtain improved outcomes for patients Why should you know this area? Domain expert and contribute as a translator, clinical voice in the room Hierarchy of AI from AI to Deep Learning Critical components of high-fidelity AI – volume of data, algorithms-built w/out confirmational bias, recurring opportunities for evolution, training the models, et. Can we include a call out to Micromedex with Watson as a specific type of AI/Use Case in everyday clinical practice? https://www.ibm.com/products/micromedex-with-watson Guests: Whitley Yi, PharmD, BCPS, Digital Health, Pharmacy Specialist at Well and Co-Founder of AI Collective Scott Nelson, PharmD, MS, CPHIMS, FAMIA, Program Director, MS Applied Clinical Informatics (MSACI), Assistant Professor, Biomedical Informatics, Assistant Clinical Director, HealthIT, Vanderbilt University Medical Center Arti Bhavsar, PharmD, Clinical Program Director, IBM Watson Health See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

How the use and training of AI-based medication management will impact hospital pharmacy. IBM® Micromedex® with Watson™ combines evidence-based drug content with advanced AI search capabilities to deliver rapid, reliable answers at the point of care. Improve care experiences and efficiency with insights into drug selection, dosing, toxicology and IV compatibility – accessible from your EHR, computer or mobile device. Primer, 101 for AI in Pharmacy – terminology, examples in med use process Augmented intelligence vs. Artificial intelligence, leveraging the strengths of computers and clinicians together to obtain improved outcomes for patients Why should you know this area? Domain expert and contribute as a translator, clinical voice in the room Hierarchy of AI from AI to Deep Learning Critical components of high-fidelity AI – volume of data, algorithms-built w/out confirmational bias, recurring opportunities for evolution, training the models, et. Can we include a call out to Micromedex with Watson as a specific type of AI/Use Case in everyday clinical practice?  https://www.ibm.com/products/micromedex-with-watson  Guests:  Whitley Yi, PharmD, BCPS, Digital Health, Pharmacy Specialist at Well and Co-Founder of AI Collective Scott Nelson, PharmD, MS, CPHIMS, FAMIA, Program Director, MS Applied Clinical Informatics (MSACI), Assistant Professor, Biomedical Informatics, Assistant Clinical Director, HealthIT, Vanderbilt University Medical Center Arti Bhavsar, PharmD, Clinical Program Director, IBM Watson Health See omnystudio.com/listener for privacy information.

In 2013, the Human Rights Campaign started tracking violence against the Transgender community in the United States. Violence against trans people has increased in recent years. In 2020, more trans people were victims of hate crimes than at any other time. So far this year, nationally, more than 30 trans people have been victims of homicide. Today on Midday, conversations with trans activists who provide services and support to Transgender people in Baltimore. Tom's first guests are Iya Dammons, the founder and executive director of Baltimore Safe Haven, a non-profit organization that advocates for a higher quality of life for TLGBQ people in Baltimore City;Melissa Deveraux is the organization's chief of staff. Later in the program, Tom is joined by Paula Neira, JD, MSN, RN, CEN, FAAN, the Clinical Program Director of the Johns Hopkins Center for Transgender Health. Our guests join us today on Zoom. See omnystudio.com/listener for privacy information.

Sports Medicine and Clinical Program Director and Physical Therapist at HHC Stefanie Bourassa Joined The Rob Dibble Show

Welcome to the Ask Why Medicine Podcast! In this introductory episode, you'll meet the hosts Gina Pritchard, MSN, RN, CNS, ACNP, DNPc; Patti DeMatteis ASDH, RDH; Lora Hooper, BSDH, RDH, EFDA; and DeWitt Wilkerson, DMD. They discuss their “why,” the goals of the podcast, and empower you to ask “why?” in your own life.Gina Pritchard, MSN, RN, CNS, ACNP, DNPcDr. Pritchard discusses her journey working in a cardiac care clinic and her transition into preventative health care. By asking “why did this individual have a heart attack or stroke in the first place?” we can now save you from those repeat hospitalizations, repeat procedures, and a potentially devastating future. Dr. Pritchard is an Acute Care Nurse Practitioner, specializing in Cardiovascular Disease Prevention and Treatment. She is the owner of The PREVENT Clinic with offices in New York and in Texas and is the Clinical Program Director for the BaleDoneen Method. She is one of the nation's leading specialists in prevention of heart attack, stroke, type 2 diabetes and vascular-related dementia. Patti DeMatteis ASDH, RDHPatti discusses her journey working with patients, answering questions like “why did I have a heart attack at a young age?” Through this podcast, we will give you the right questions to ask, to ensure you don't have comorbidities and that your immune system is strong to fight off any infections or viruses that may come your way.Patti is the founder of DHEmethod. Patti is a founding member of The American Academy for Oral Systemic Health and a Preceptor for the BaleDoneen Method. Her passion for dentistry focuses on comprehensive patient care and helping dental colleagues enjoy their profession in the fast paced oral-systemic movement toward prevention and wellness. Lora Hooper, BSDH, RDH, EFDALora discusses the transformation we want to provide with this podcast, that you can go from feeling frustrated and hopeless in your health, to feeling confident, and knowing that you can live a long healthy life.  Through this podcast, we will bring you stories of people who are reversing chronic inflammatory disease such as cardiovascular disease and diabetes. It is possible! We will bring you the leading scientists, experts, and top answers to the most pressing questions in our healthcare system.Lora is the co-owner of DHEmethod. She continues to work in private practice while running her business as a dental consultant. Her passion lies in improving the quality of life for every patient by implementing oral-systemic care into practice through the DHEmethod.Witt Wilkerson, DMDDr. Wilkerson discusses lifestyle factors versus genetics in disease progression and the new model of healthcare titled “integrative medicine.” The goal of the Ask Why Medicine Podcast is to ask all the questions and bring you the best experts, to find the answers to help you, your families, and your communities live longer and healthier lives.Dr. Wilkerson is a partner of Dr. Peter Dawson's private practice. He serves as a Senior Faculty/Lecturer and Director of Dental Medicine with the Dawson Academy, is a Past-President of the AAOSH, Past-President of the AES, Director of Dental Medicine at the Dawson Academy, Adjunct Professor of Graduate Studies at the University of Florida College of Dentistry, and former Associate Faculty and Special Lecturer at the L.D. Pankey Institute. Social MediaInstagram: @askwhymedicineFacebook: @askwhymedicine

In this episode, we are talking with Vanessa Brenner. Vanessa is the Clinical Program Director at the Hanley Center at Origins.   Vanessa shares about her journey from the finance industry to being a family counselor and recently returning to the women’s unit as the Program Director. She shares the impact kind words and encouragement have on her own life and how life-giving it can be to offer the same to others. She also shares about being genuine and honest with others even when it can be tough.  Show Notes: [00:39] We are excited to welcome Vanessa Brenner. Vanessa is the Clinical Program Director at the Hanley Center at Origins.  [01:20] She is a licensed mental health counselor in the state of Florida. She has been living in Florida since 2008 and prior to coming to Florida, she worked in the finance industry.  [02:54] When she changed industries and went back to school, she knew from the very beginning that she wanted to work with addicts and alcoholics. [04:37] When she came to Hanley, she started working with families. She is a family counselor, mother, fiance, and exerciser.  [06:30] She is returning as the Program Director of the women’s unit.    [08:38] We are all human. There are times when we feel very frustrated, stuck, and that we are not getting anywhere.   [10:13] It is okay to be stuck. There is hope. We are not going to be stuck forever. Kind words or encouragement can often help someone get out of their rut. [11:21] Think about where you can be that encouragement for others.   [12:58] You have no idea the impact you can make when reaching out to someone. Vanessa keeps a special email folder with notes of encouragement she has received.   [14:47] It isn’t about the big things. It is about the little things we can do to support and encourage others.   [15:58] Her own alcoholism and experimenting with drug use brought her to a place where she knew she wanted to help people.   [17:02] She felt like she wanted to share her human experience with others.   [19:25] Drinking was a very big part of the culture she was immersed in, but not her home culture. [20:26] She suffered serious consequences from her drinking and that sealed the deal that she didn’t want to go on like that. She did some treatment, got a sponsor, and worked the Twelve Steps.  [21:34] You can live with this and have a happy life sober. It is not easy sometimes, but it is a lot easier than the other way.   [23:32] Being genuine is telling people the truth. The truth isn’t always easy, but it is necessary.   [24:51] Everyone of us is going to encounter people and that means that we have multiple opportunities for an act of kindness and something that can build people up. Look for the moments to build someone up today.     [26:39] We have opportunities to build someone up and help them get out of the rut that we all struggle with.  Links and Resources: Something More Podcast Origins Website Origins on Facebook Origins on Instagram  

As COVID-19 vaccines become available to the general population, retail pharmacies will play a pivotal role in vaccine administration. Learn how Harps Food Stores is implementing key strategies and following best practice recommendations to prepare for increased workload and required safety precautions. Guests Duane Jones, BS Pharm, Clinical Program Director and Pharmacy District Manager, Harps Food Stores, Inc. Mike Cantrell, RPh, Esq., Sr. Director Regional Operations, EnlivenHealth™ Hosted by Ken Perez, Vice President of Healthcare Policy, Omnicell https://www.omnicell.com/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

As COVID-19 vaccines become available to the general population, retail pharmacies will play a pivotal role in vaccine administration. Learn how Harps Food Stores is implementing key strategies and following best practice recommendations to prepare for increased workload and required safety precautions. Guests Duane Jones, BS Pharm, Clinical Program Director and Pharmacy District Manager, Harps Food Stores, Inc. Mike Cantrell, RPh, Esq., Sr. Director Regional Operations, EnlivenHealth™ Hosted by Ken Perez, Vice President of Healthcare Policy, Omnicell https://www.omnicell.com/podcast  See omnystudio.com/listener for privacy information.

As COVID-19 vaccines become available to the general population, retail pharmacies will play a pivotal role in vaccine administration. Learn how Harps Food Stores is implementing key strategies and following best practice recommendations to prepare for increased workload and required safety precautions. Guests Duane Jones, BS Pharm, Clinical Program Director and Pharmacy District Manager, Harps Food Stores, Inc. Mike Cantrell, RPh, Esq., Sr. Director Regional Operations, EnlivenHealth™ Hosted by Ken Perez, Vice President of Healthcare Policy, Omnicell https://www.omnicell.com/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week, Michael Kahn interviews Sean O'Brien, Professor at Clinical Program Director at the University of Missouri-Kansas City School of Law. In pt. 1, Sean shares some of the struggles he faces in representing innocent persons on death row. He describes the immense stress & pressures that come with the work, the challenges of battling the appalling injustices that many people encounter, and how he has been able to keep at it for all these years. Come back next week for pt. 2!

Emily Harman, host of Onward Podcast, interviews her Naval Academy classmate and Clinical Program Director of the John Hopkins Center for Transgender Health, Paula Neira. Paula shares how she overcame a traumatic loss (her naval career) but kept moving forward, being consistent in her core values. In moving onward, Paula realized her calling in life was broader than just serving in the Navy and that she has been blessed with the opportunity to help others in many ways.      Episode Highlights: Paula explains the history of transgender individuals serving in the U.S. military. Paula shares why she decided to attend the U.S. Naval Academy. Paula explains why she had to leave the Navy and end her naval career. Paula shares important lessons (things to do or not do) that she learned from dealing with her greatest adversity. Paula discusses past suicidal thoughts. What does it take to respond to discrimination?   What questions does Paula typically get asked about being transgender? Paula explains her role as co-sponsor of the new USNS Harvey Milk, an underway replenishment oiler. Paula and Emily talk about how we don’t always know the grand plan for our lives - your life is your life. There is no “supposed to be.” Paula explains how her experience shaped how she approaches her current job  as Clinical Program Director of the John Hopkins Center for Transgender Health. Most societal change happens incrementally. What should a parent do if their child questions their gender identity and how did Paula’s parents react? In times of adversity, you have to take care of yourself and ask for help when it is needed. Paula shares that her Naval Academy classmates have treated with respect since she identified as transgender.     3 Key Points: Our country is stronger because of our diversity. People should not be denied opportunity ( i.e to serve or access medically necessary care) based on other’s prejudice. The struggle to move our country forward is often fraught with adversity and we have to keep going. For people who fight for civil rights or social justice, there are some important things to consider: Be Resolute (Never Surrender, Live by Your Core Values) Be Strategic (Make decisions based on achieving victory and not satisfying emotion/ego) Be Healthy (Self-care, Realistic perspectives, Patience)   Tweetable Quotes: “The only direction you can go in after dealing with adversity is forward.” – Paula Neira “It didn’t matter how good I was at my job. It didn’t matter how dedicated I was. It didn’t matter what skills I had. The only thing that mattered was that my gender identity didn’t align with the sex that I was assigned at birth.” – Paula Neira “Part of being a leader is taking care of your people, and we’ve put into place regulations that prevent them from doing that.” – Paula Neira   Resources Mentioned: Paula Neira: Linkedin Listeners can contact Paula at work via email pneira2@jhmi.edu or phone 443-287-7161   Veterans Crisis Line: 1-800-273-8255 press 1 The Veterans Crisis Line is a free, confidential resource that’s available to anyone, even if you’re not registered with VA or enrolled in VA health care. The caring, qualified responders at the Veterans Crisis Line are specially trained and experienced in helping Veterans of all ages and circumstances.   The Trevor Project: 1-866-488-7386 www.thetrevorproject.org The Trevor Project is the leading national organization providing crisis intervention and suicide prevention services to lesbian, gay, bisexual, transgender, queer & questioning (LGBTQ) young people under 25.   JHCTH (Johns Hopkins Center for Transgender Health) 844-546-5645 https://www.hopkinsmedicine.org/center_transgender_health/index.html The mission of the Johns Hopkins Center for Transgender Health is to reduce health care disparities and improve the overall health of the transgender community through world-class clinical care, medical education and research. Embracing diversity and inclusion, the Center for Transgender Health provides affirming, objective, person-centered care to improve health and enhance wellness; educates interdisciplinary health care professionals to provide culturally competent, evidence-based care; informs the public on transgender health issues; and advances medical knowledge by conducting biomedical research.  

In recent years, the world of professional sports and athletics has 'woken up' to the idea that sleep plays a vitally important role in optimizing athletic ability and performance.  Today we're talking to Dr Amy M. Bender, a sleep scientist who has spent her life involved in many competitive sports activities, about the importance of sleep with regards to fitness, exercise and sports, but not just for competitive athletes, but for anyone who wants to ensure they're making the most of their fitness regime.  This episode's guest:   Dr Amy M. Bender is currently a Senior Research Scientist at Calgary Counselling Centre. Previously she was the Clinical Program Director of Athlete Services at Centre for Sleep and Human Performance and  also an Adjunct Assistant Professor of Kinesiology at University of Calgary. She received her PhD and Master of Science degrees in Experimental Psychology from Washington State University specializing in sleep EEG.  She has developed sleep intervention protocols for numerous Canadian National Teams. She's an athlete herself, a Hall of Fame basketball player, has summited a handful of volcanoes, completed an Ironman in 2009, and is also mom to 3 young children all under the age of five. Resources: Twitter @sleep4sport : https://twitter.com/Sleep4Sport Instagram @sleep4sport: https://www.instagram.com/sleep4sport LinkedIn: https://www.linkedin.com/in/amy-m-bender-ms-phd-b8087884/ Athlete Sleep Screening Questionnaire: https://www.ncbi.nlm.nih.gov/pubmed/29869021 Sleep Fitness Infographic: http://sleepjunkies.com/sleep-fitness-routine/ More Episodes:

In recent years, the world of professional sports and athletics has 'woken up' to the idea that sleep plays a vitally important role in optimizing athletic ability and performance.  Today we're talking to Dr Amy M. Bender, a sleep scientist who has spent her life involved in many competitive sports activities, about the importance of sleep with regards to fitness, exercise and sports, but not just for competitive athletes, but for anyone who wants to ensure they're making the most of their fitness regime.  This episode’s guest:   Dr Amy M. Bender is currently a Senior Research Scientist at Calgary Counselling Centre. Previously she was the Clinical Program Director of Athlete Services at Centre for Sleep and Human Performance and  also an Adjunct Assistant Professor of Kinesiology at University of Calgary. She received her PhD and Master of Science degrees in Experimental Psychology from Washington State University specializing in sleep EEG.  She has developed sleep intervention protocols for numerous Canadian National Teams. She's an athlete herself, a Hall of Fame basketball player, has summited a handful of volcanoes, completed an Ironman in 2009, and is also mom to 3 young children all under the age of five. Resources: Twitter @sleep4sport : https://twitter.com/Sleep4Sport Instagram @sleep4sport: https://www.instagram.com/sleep4sport LinkedIn: https://www.linkedin.com/in/amy-m-bender-ms-phd-b8087884/ Athlete Sleep Screening Questionnaire: https://www.ncbi.nlm.nih.gov/pubmed/29869021 Sleep Fitness Infographic: https://sleepjunkies.com/sleep-fitness-routine/ More Episodes:

Dr. Bender is Clinical Program Director of Athlete Services at the Centre for Sleep and Human Performance and is also an Adjunct Assistant Professor of Kinesiology at the University of Calgary. She received her PhD and Master of Science degrees in Experimental Psychology from Washington State University specializing in sleep EEG. Her current research focuses on optimizing sleep in Canadian Olympic Team athletes and the impact on performance. Her research interests stem from being an athlete herself; she is a Hall of Fame basketball player, has enjoyed some mountaineering, completed an Ironman in 2009, and currently runs after her 3 children who are all 5 and under. She is driven to help high-performers optimize sleep to enhance their well-being and productivity.  Catch her on Twitter @sleep4sport 

How much sleep do we actually need?  What is the best way to fall asleep?  How do you deal with jet lag?  Today's jam-packed episode is about everything sleep related.  I had the luxury of talking to a sleep expert, Dr. Amy Bender. Dr. Bender is currently the Clinical Program Director of Athlete Services at Centre for Sleep and Human Performance and is also an Adjunct Assistant Professor of Kinesiology at University of Calgary. She received her PhD and Master of Science degrees in Experimental Psychology from Washington State University specializing in sleep EEG. Her current research focuses on the relationship of sleep and recovery on athletic performance. She has developed sleep intervention protocols for numerous Canadian National Teams. Her research interests stem from being an athlete herself; she is a Hall of Fame basketball player, has summited a handful of volcanoes, completed an Ironman in 2009, and currently runs around chasing her 3 children who are all 5 and under. I hope you enjoy all the great information in this episode and that it helps you sleep better and recover faster! Topics Discussed in the Podcast  Sleep cycles, circadian rhythms how much sleep do you need, can you bank sleep, are naps helpful? sleep needs for athletes sleep and recovery for athletes cortisol, adenosine, caffeine sleep hygeine how to manage sleep when you have kids how to adapt to jet lag and get on a sleep schedule tips for falling asleep ideal bedtime  Listen Now     Links Amy's instagram Link to Athlete Sleep Screening Questionairre Centre for Sleep - Calgary   Join! Plant-Powered Tribe Facebook Group Shop My Store – Moxy & Grit The Best Mountain Bike Vacation EVER! Join me in Bend, Oregon Oct 4-7   Support the Show If you would like to support the growth my show, I'd love your contribution on.  Patreon.  The current production of this free show is primarily supported out of my own pocket and a small portion is covered through the donations on Patreon. With my Patreon page, you can donate directly to the show which will help me cover the costs and help it grow! Even 4 bucks a month- the cost of one coffee per month helps a LOT! Thanks, I really appreciate your support! Crowdfunding on Patreon – thank you! Shop my products!  Leave a review or share on social media Don't forget to subscribe! Apple Podcasts Stitcher Google Play Spotify Thanks for listening!  

goodathleteproject.com For today's episode we sat down with Dr. Amy Bender, Clinical Program Director of Athlete Services at the Centre for Sleep & Human Performance. In addition to her work at the Centre for Sleep & Human Performance, Dr. Bender is also an adjunct professor of Kinesiology at the University of Calgary. Her research interests stem from being an athlete herself; she is a Hall of Fame basketball player, has summited a number of volcanoes, and completed an Ironman in 2009. You can find Dr. Bender on Twitter: @Sleep4Sport and learn more about the Centre for Sleep & Human Performance at their website centreforsleep.com Today's Episode brought to you by Remind Recover. You can find them at Remindrecover.com and on Twitter and Instagram: @ReMindRecover. Use the code: GoodAthlete at checkout for a discount on your next order. Follow us on Twitter and Instagram: @Coach4Kindness Follow and like us on Facebook: www.facebook.com/coach4kindness/

Sleep researcher Dr. Amy Bender discusses the most current evidence-based recommendations for optimizing your sleep for health and athletic performance. Dr. Bender is the Clinical Program Director of Athlete Services at the Centre for Sleep & Human Performance and is also an adjunct professor of Kinesiology at the University of Calgary. She received her PhD and Master of Science degrees in Experimental Psychology from Washington State University in Spokane, WA specializing in sleep EEG. Her current research focuses on the relationship of sleep and recovery on athletic performance in Canadian National Team athletes. Her research interests stem from being an athlete herself; she is a Hall of Fame basketball player, has summited a number of volcanoes, and completed an Ironman in 2009. In This Episode We Discuss: Circadian biology and light/dark cycles Effects of artificial light at night The importance of daylight exposure early in the day Daily vs. weekly sleep quantity What exactly is "good quality" sleep? Strategy of "banking sleep" Assessing and tracking sleep in clients and athletes Strategies to mitigate detrimental effects of sleep before competition Are there any supplements that actually work for helping sleep? Interested in doing an online nutrition course? Check out sigmanutrition.com/mnu